Cochrane Abstracts
Positron emission tomography‐adapted therapy for first‐line treatment in individuals with Hodgkin lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Positron Emission Tomography‐adapted Therapy for First‐line Treatment in Individuals With Hodgkin Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436905/all/Positron_emission_tomography‐adapted_therapy_for_first‐line_treatment_in_individuals_with_Hodgkin_lymphoma.
Positron emission tomography‐adapted therapy for first‐line treatment in individuals with Hodgkin lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436905/all/Positron_emission_tomography‐adapted_therapy_for_first‐line_treatment_in_individuals_with_Hodgkin_lymphoma. Accessed December 3, 2024.
Positron emission tomography‐adapted therapy for first‐line treatment in individuals with Hodgkin lymphoma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436905/all/Positron_emission_tomography‐adapted_therapy_for_first‐line_treatment_in_individuals_with_Hodgkin_lymphoma
Positron Emission Tomography‐adapted Therapy for First‐line Treatment in Individuals With Hodgkin Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436905/all/Positron_emission_tomography‐adapted_therapy_for_first‐line_treatment_in_individuals_with_Hodgkin_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Positron emission tomography‐adapted therapy for first‐line treatment in individuals with Hodgkin lymphoma
ID - 436905
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436905/all/Positron_emission_tomography‐adapted_therapy_for_first‐line_treatment_in_individuals_with_Hodgkin_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
